An exploratory study to assess the RSV titer in healthy volunteers as guidance for the main study

An exploratory study to assess the RSV titer in healthy volunteers as guidance for the main study - RSV titer assessment in healthy adult volunteers

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44515

Enrollment

100

Registered

2017-06-09

Start date

2017-06-15

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

common cold RSV infection

Interventions

reference

titer

antibody

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1.Healthy male or female subjects, 18-45 years of age, inclusive; 2.Signed informed consent prior to any study-mandated procedure 3. Has the ability to communicate well with the Investigator in the Dutch language

Exclusion criteria

Exclusion criteria: 1. Immune-compromised individuals (known or expected immune deficiency, disease or use of medication that may affect the immune system); 2. Chronic airway diseases; 3. Airway infection / common cold within 14 days prior to blood sample collection; 4. Hay fever or other allergies that involve the airways; 5. Blood donation would result in loss of blood outside the limits of the national blood bank (>500 mL within 90 days.

Design outcomes

Primary

Measure	Time frame
Virus neutralization titer levels against RSV	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)